191R RITE AID 11822 3311 SENNA LAXATIVE TABLETS
- Manufacturer
- RITE AID | TIME CAP LABORATORIES, INC.
- Effective date
- 2021-10-28
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-05-31 23:44:37
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Sennosides 8.6 mg
OTC - PURPOSE SECTION
Purpose
Laxative
INDICATIONS & USAGE SECTION
Uses
- relieves occasional constipation (irregularity)
- generally causes bowel movement in 6-12 hours
WARNINGS SECTION
Warnings
OTC - DO NOT USE SECTION
Do not use
- laxative products for longer than 1 week unless directed by a doctor
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel movements that continues over a period of 2 weeks
OTC - STOP USE SECTION
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- take preferably at bedtime or as directed by a doctor
- if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable
age starting
dosagemaximum
dosage
adults and children 12 years and over
2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
- if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable
OTHER SAFETY INFORMATION
Other information
- each tablet contains: calcium 25 mg, sodium 2 mg (VERY LOW SODIUM)
- store at 25°C (77°F) excursions permitted between 15°- 30°C (59°- 86°F)
INACTIVE INGREDIENT SECTION
Inactive ingredients croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil
OTC - QUESTIONS SECTION
Questions or comments? Call 1-877-290-4008
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11822-3311-5 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-7874-d83d-e063-dadaa90ab31f | 191R RITE AID 11822 3311 SENNA LAXATIVE TABLETS |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11822-3311-5 | SENNA | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11822-3311 | SENNA (SENNOSIDES) TABLET, COATED [RITE AID] | 2 | Legacy NDC, 1 package rows | 20211031_ad407c0d-8e13-873f-e053-2995a90aa8fa.zip |
Products#
Every source-derived product name is available through these pages.
- SENNA
- SENNOSIDES
- CROSCARMELLOSE SODIUM
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- HYPROMELLOSES
- MAGNESIUM STEARATE
- CELLULOSE, MICROCRYSTALLINE
- MINERAL OIL
- SENNOSIDES A AND B
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11822-3311 | 11822-3311-5 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| CELLULOSE, MICROCRYSTALLINE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| SENNOSIDES A AND B | 1B5FPI42EN | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cf693c9e-9b3e-44da-e053-2a95a90ad2e9 | ad407c0d-8e13-873f-e053-2995a90aa8fa | 2021-10-28 | Warnings | cf693c9e-9b3e-44da-e053-2a95a90ad2e9 ad407c0d-8e13-873f-e053-2995a90aa8fa |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

